NSTL国家科技图书文献中心

1. Extracorporeal liver support and liver transplantation for acute‐on‐chronic liver failure NSTL国家科技图书文献中心

Maria Pilar Balleste... | Ahmed Elshabrawi ... - 《Liver international》 - 2025,45(3) - e15647～e15647 - 共12页

摘要：Abstract Acute‐on‐chronic liver* failure (ACLF* | . During the last decades, several extracorporeal liver | ongoing liver* injury and provide an improved environment* | for the liver* to regenerate or as a bridging therapy* | until liver* transplantation. Several clinical trials*

关键词： acute‐on‐chronic liver failure | liver support systems | liver transplantation

2. Liver support systems and liver transplantation in acute liver failure NSTL国家科技图书文献中心

Larsen, Fin S. | Saliba, Faouzi - 《Liver international》 - 2025,45(3) - e15633～e15633 - 共8页

摘要：Acute liver* failure (ALF) results in a* | liver support and liver transplantation (LT). The | the failing liver. The first is the development of | hyperammonemia, as the liver* can no longer synthesize urea. The* | necrotic liver* cells that release large molecules that*

关键词： acute liver failure | albumin dialysis | ammonia | hepatic encephalopathy | liver support | liver transplantation | plasma exchange

3. Drug-Induced Liver Injury in Patients With Chronic Liver Disease NSTL国家科技图书文献中心

Ghabril, Marwan | Vuppalanchi, Raj ... - 《Liver international》 - 2025,45(3) - e70019～e70019 - 共13页

摘要：ObjectiveDrug-induced liver* injury (DILI) is a* | is clinically challenging, and liver* injury can be* | severe leading to liver failure, death, or liver | transplantation. Patients with underlying chronic liver* diseases* | associated with factors related to drug or liver* disease*

关键词： acute-on-chronic liver failure | chronic liver disease | drug-induced liver injury | acute‐on‐chronic liver failure | drug‐induced liver injury

4. Genetic Risk Factors for Steatotic Liver Disease After Liver Transplantation NSTL国家科技图书文献中心

Liukkonen, Ville | Semenova, Maria ... - 《Liver international》 - 2025,45(4) - e70067～e70067 - 共13页

摘要： steatotic liver disease (SLD) is intriguing in liver | -recipient pairs with liver* biopsy available >= 6 months* | BackgroundThe role of genetic risk factors for | transplantation (LT), as both donor and recipient genetic | factors may play a role. There are only a few small

关键词： fatty liver | genetics | liver transplantation | polygenic risk score | steatotic liver disease

5. Liver transplantation and primary liver cancer in porphyria NSTL国家科技图书文献中心

Mattias Lissing | Bruce Wang ... - 《Liver international》 - 2025,45(3) - e15894～e15894 - 共8页 - 被引量：1

摘要： symptoms and complications that require liver | high risk for primary liver* cancer (PLC). Among the* | ) can lead to cholestatic liver* failure where LT cures* | the liver* disease but not the porphyria. In acute* | produced in the liver* and LT is a curative treatment*

关键词： acute porphyria | erythropoetic porphyria | liver neoplasms | liver transplantation | metabolic diseases | porphyria

6. Identification of Distinguishing Features of Drug‐Induced Liver Injury and Liver Injury Associated With Sepsis NSTL国家科技图书文献中心

Egill Logason | Sigurdur Sölvi Sigur...... - 《Liver international》 - 2025,45(5) - e70090～e70090 - 共11页

摘要： difficult to distinguish between drug‐induced liver* injury* | (DILI) and liver* injury associated with sepsis (sepsis* | induced liver* injury, SILI). The aims of the study were* | DILI had normal liver* tests 2 weeks after the event* | with a HC pattern of liver* injury favours the*

关键词： drug‐induced liver injury | hepatotoxicity | liver injury | sepsis

7. Liver Injury due to Intravenous Methylprednisolone in the Drug-Induced Liver Injury Network NSTL国家科技图书文献中心

Ahmad, Jawad | Li, Yi-Ju ... - 《Liver international》 - 2025,45(2) - e16242～e16242 - 共9页 - 被引量：2

摘要： induced liver* injury (DILI). The aim of this study was* | sclerosis (MS). Liver* biopsies in 7 cases revealed mild* | Background and AimsShort courses of | intravenous (iv) methylprednisolone (MP) can cause drug | to assess the clinical features and HLA

关键词： drug induced liver injury | HLA genotype associations | methylprednisolone | multiple sclerosis

8. Neutrophil plasticity in liver diseases NSTL国家科技图书文献中心

Teo, Jia Ming Nickol... | Chen, Weixin ... - 《Journal of Leukocyte Biology》 - 2025,117(3) - qiae222～qiae222 - 共11页

摘要：The liver* has critical digestive, metabolic* | during liver* diseases such as viral hepatitis, fatty* | liver disease, and hepatocellular carcinoma. While | these diseases has focused on liver-resident immune | state, during liver* disease, and during liver cancer.*

关键词： disease pathogenesis | liver | neutrophils

9. Acute Liver Failure NSTL国家科技图书文献中心

Roehlen, Natascha | Thimme, Robert - 《DMW》 - 2025,150(7) - 371～384 - 共14页

摘要：Acute liver* failure (ALF) is a severe* | , potentially reversible form of liver* insufficiency, which is* | hepatic disease. Acute liver* failure is preceded by* | severe acute liver* injury (ALI) with an increase in* | on the background of toxic liver* injury (e.g. drug*

关键词： akute Lebersch & auml;digung | Leberinsuffizienz | Lebertransplantation | acute liver injury | liver transplantation | liver insufficiency | akute Leberschädigung

10. Acute and non‐acute decompensation of liver cirrhosis (47/130) NSTL国家科技图书文献中心

Martin S. Schulz | Paolo Angeli ... - 《Liver international》 - 2025,45(3) - e15861～e15861 - 共14页 - 被引量：2

摘要： liver failure (ACLF) has been established as a | earlier stage of chronic liver* disease. Successful* | Abstract In the traditional view, the | occurrence of cirrhosis‐related complications, such as | hepatic encephalopathy, formation of ascites or variceal

摘要：Abstract Acute‐on‐chronic liver* failure (ACLF* | . During the last decades, several extracorporeal liver | ongoing liver* injury and provide an improved environment* | for the liver* to regenerate or as a bridging therapy* | until liver* transplantation. Several clinical trials*

关键词： acute‐on‐chronic liver failure | liver support systems | liver transplantation

摘要：Acute liver* failure (ALF) results in a* | liver support and liver transplantation (LT). The | the failing liver. The first is the development of | hyperammonemia, as the liver* can no longer synthesize urea. The* | necrotic liver* cells that release large molecules that*

关键词： acute liver failure | albumin dialysis | ammonia | hepatic encephalopathy | liver support | liver transplantation | plasma exchange

摘要：ObjectiveDrug-induced liver* injury (DILI) is a* | is clinically challenging, and liver* injury can be* | severe leading to liver failure, death, or liver | transplantation. Patients with underlying chronic liver* diseases* | associated with factors related to drug or liver* disease*

关键词： acute-on-chronic liver failure | chronic liver disease | drug-induced liver injury | acute‐on‐chronic liver failure | drug‐induced liver injury

摘要： steatotic liver disease (SLD) is intriguing in liver | -recipient pairs with liver* biopsy available >= 6 months* | BackgroundThe role of genetic risk factors for | transplantation (LT), as both donor and recipient genetic | factors may play a role. There are only a few small

关键词： fatty liver | genetics | liver transplantation | polygenic risk score | steatotic liver disease

摘要： symptoms and complications that require liver | high risk for primary liver* cancer (PLC). Among the* | ) can lead to cholestatic liver* failure where LT cures* | the liver* disease but not the porphyria. In acute* | produced in the liver* and LT is a curative treatment*

关键词： acute porphyria | erythropoetic porphyria | liver neoplasms | liver transplantation | metabolic diseases | porphyria

摘要： difficult to distinguish between drug‐induced liver* injury* | (DILI) and liver* injury associated with sepsis (sepsis* | induced liver* injury, SILI). The aims of the study were* | DILI had normal liver* tests 2 weeks after the event* | with a HC pattern of liver* injury favours the*

关键词： drug‐induced liver injury | hepatotoxicity | liver injury | sepsis

摘要： induced liver* injury (DILI). The aim of this study was* | sclerosis (MS). Liver* biopsies in 7 cases revealed mild* | Background and AimsShort courses of | intravenous (iv) methylprednisolone (MP) can cause drug | to assess the clinical features and HLA

关键词： drug induced liver injury | HLA genotype associations | methylprednisolone | multiple sclerosis

摘要：The liver* has critical digestive, metabolic* | during liver* diseases such as viral hepatitis, fatty* | liver disease, and hepatocellular carcinoma. While | these diseases has focused on liver-resident immune | state, during liver* disease, and during liver cancer.*

关键词： disease pathogenesis | liver | neutrophils

摘要：Acute liver* failure (ALF) is a severe* | , potentially reversible form of liver* insufficiency, which is* | hepatic disease. Acute liver* failure is preceded by* | severe acute liver* injury (ALI) with an increase in* | on the background of toxic liver* injury (e.g. drug*

关键词： akute Lebersch & auml;digung | Leberinsuffizienz | Lebertransplantation | acute liver injury | liver transplantation | liver insufficiency | akute Leberschädigung

摘要： liver failure (ACLF) has been established as a | earlier stage of chronic liver* disease. Successful* | Abstract In the traditional view, the | occurrence of cirrhosis‐related complications, such as | hepatic encephalopathy, formation of ascites or variceal

关键词： ACLF | acute decompensation | acute‐on‐chronic liver failure | liver cirrhosis | non‐acute decompensation

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Abstract Acute‐on‐chronic liver failure (ACLF | . During the last decades, several extracorporeal liver | ongoing liver injury and provide an improved environment | for the liver to regenerate or as a bridging therapy | until liver transplantation. Several clinical trials

关键词： acute‐on‐chronic liver failure | liver support systems | liver transplantation

摘要：Acute liver failure (ALF) results in a | liver support and liver transplantation (LT). The | the failing liver. The first is the development of | hyperammonemia, as the liver can no longer synthesize urea. The | necrotic liver cells that release large molecules that

关键词： acute liver failure | albumin dialysis | ammonia | hepatic encephalopathy | liver support | liver transplantation | plasma exchange

摘要：ObjectiveDrug-induced liver injury (DILI) is a | is clinically challenging, and liver injury can be | severe leading to liver failure, death, or liver | transplantation. Patients with underlying chronic liver diseases | associated with factors related to drug or liver disease

关键词： acute-on-chronic liver failure | chronic liver disease | drug-induced liver injury | acute‐on‐chronic liver failure | drug‐induced liver injury

摘要： steatotic liver disease (SLD) is intriguing in liver | -recipient pairs with liver biopsy available >= 6 months | BackgroundThe role of genetic risk factors for | transplantation (LT), as both donor and recipient genetic | factors may play a role. There are only a few small

关键词： fatty liver | genetics | liver transplantation | polygenic risk score | steatotic liver disease

摘要： symptoms and complications that require liver | high risk for primary liver cancer (PLC). Among the | ) can lead to cholestatic liver failure where LT cures | the liver disease but not the porphyria. In acute | produced in the liver and LT is a curative treatment

关键词： acute porphyria | erythropoetic porphyria | liver neoplasms | liver transplantation | metabolic diseases | porphyria

摘要： difficult to distinguish between drug‐induced liver injury | (DILI) and liver injury associated with sepsis (sepsis | induced liver injury, SILI). The aims of the study were | DILI had normal liver tests 2 weeks after the event | with a HC pattern of liver injury favours the

关键词： drug‐induced liver injury | hepatotoxicity | liver injury | sepsis

摘要： induced liver injury (DILI). The aim of this study was | sclerosis (MS). Liver biopsies in 7 cases revealed mild | Background and AimsShort courses of | intravenous (iv) methylprednisolone (MP) can cause drug | to assess the clinical features and HLA

关键词： drug induced liver injury | HLA genotype associations | methylprednisolone | multiple sclerosis

摘要：The liver has critical digestive, metabolic | during liver diseases such as viral hepatitis, fatty | liver disease, and hepatocellular carcinoma. While | these diseases has focused on liver-resident immune | state, during liver disease, and during liver cancer.

关键词： disease pathogenesis | liver | neutrophils

摘要：Acute liver failure (ALF) is a severe | , potentially reversible form of liver insufficiency, which is | hepatic disease. Acute liver failure is preceded by | severe acute liver injury (ALI) with an increase in | on the background of toxic liver injury (e.g. drug

关键词： akute Lebersch & auml;digung | Leberinsuffizienz | Lebertransplantation | acute liver injury | liver transplantation | liver insufficiency | akute Leberschädigung

摘要： liver failure (ACLF) has been established as a | earlier stage of chronic liver disease. Successful | Abstract In the traditional view, the | occurrence of cirrhosis‐related complications, such as | hepatic encephalopathy, formation of ascites or variceal

关键词： ACLF | acute decompensation | acute‐on‐chronic liver failure | liver cirrhosis | non‐acute decompensation

4008-161-200 800-990-8900

国家科技图书文献中心

摘要：Abstract Acute‐on‐chronic liver* failure (ACLF* | . During the last decades, several extracorporeal liver | ongoing liver* injury and provide an improved environment* | for the liver* to regenerate or as a bridging therapy* | until liver* transplantation. Several clinical trials*

摘要：Acute liver* failure (ALF) results in a* | liver support and liver transplantation (LT). The | the failing liver. The first is the development of | hyperammonemia, as the liver* can no longer synthesize urea. The* | necrotic liver* cells that release large molecules that*

摘要：ObjectiveDrug-induced liver* injury (DILI) is a* | is clinically challenging, and liver* injury can be* | severe leading to liver failure, death, or liver | transplantation. Patients with underlying chronic liver* diseases* | associated with factors related to drug or liver* disease*

摘要： steatotic liver disease (SLD) is intriguing in liver | -recipient pairs with liver* biopsy available >= 6 months* | BackgroundThe role of genetic risk factors for | transplantation (LT), as both donor and recipient genetic | factors may play a role. There are only a few small

摘要： symptoms and complications that require liver | high risk for primary liver* cancer (PLC). Among the* | ) can lead to cholestatic liver* failure where LT cures* | the liver* disease but not the porphyria. In acute* | produced in the liver* and LT is a curative treatment*

摘要： difficult to distinguish between drug‐induced liver* injury* | (DILI) and liver* injury associated with sepsis (sepsis* | induced liver* injury, SILI). The aims of the study were* | DILI had normal liver* tests 2 weeks after the event* | with a HC pattern of liver* injury favours the*

摘要： induced liver* injury (DILI). The aim of this study was* | sclerosis (MS). Liver* biopsies in 7 cases revealed mild* | Background and AimsShort courses of | intravenous (iv) methylprednisolone (MP) can cause drug | to assess the clinical features and HLA

摘要：The liver* has critical digestive, metabolic* | during liver* diseases such as viral hepatitis, fatty* | liver disease, and hepatocellular carcinoma. While | these diseases has focused on liver-resident immune | state, during liver* disease, and during liver cancer.*

摘要：Acute liver* failure (ALF) is a severe* | , potentially reversible form of liver* insufficiency, which is* | hepatic disease. Acute liver* failure is preceded by* | severe acute liver* injury (ALI) with an increase in* | on the background of toxic liver* injury (e.g. drug*

摘要： liver failure (ACLF) has been established as a | earlier stage of chronic liver* disease. Successful* | Abstract In the traditional view, the | occurrence of cirrhosis‐related complications, such as | hepatic encephalopathy, formation of ascites or variceal